Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (7815)	11/24/1998 7:11:00 PM
From: aknahow	Respond to of 17367

Define ally! I know ally and have been told that he is no Al lie. "....made in anticipation of possible future approvals and commercialization of NEUPREX® and other products,...." I still must read this as a decision made due to a possible event. If such an event were not possible, I doubt you would buy stock in XOMA. So nothing has changed, nothing is new. Approval of Neuprex and other drugs is a possible future event. Will such events occur? I don't know, but it is possible!

To: Bluegreen who wrote (7815)	11/24/1998 7:20:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

Maybe this might make things clearer. Xoma wanting to have new domicile in Bermuda puts what connotation on statement about anticipating possible approval of Neuprex? There is also possibility of Neuprex NOT getting approval so why not keep same domicile? Now in my opinion, Xoma is not anticipating that great of a possibility of non approval, they are anticipating the possibility of approval of Neuprex hence wanting change of domicile. This is the best I can do in explaining anticipating possibilities and actions proposed by parties in regard to such anticipation of certain possibilities.<g>